• July 22, 2010
    Study shows once-daily, extended-release formulation of nevirapine was not inferior to twice-daily VIRAMUNE in treatment-naïve HIV-1 infected patients
  • June 26, 2010
    Boehringer Ingelheim announces pivotal phase III data showing linagliptin reduced blood sugar compared to placebo in people with type 2 diabetes
  • June 18, 2010
    Boehringer Ingelheim Comments on June 18th FDA Advisory Committee Meeting
  • June 17, 2010
    Key Facts on HSDD and Flibanserin
  • June 14, 2010
    New Game on Facebook Helps People with Diabetes Improve Everyday Behaviors
  • June 13, 2010
    Boehringer Ingelheim affirms safety of telmisartan with an analysis of 50,000 patients and strongly disagrees with the publication of Sipahi et al in Lancet Oncology June 2010
  • June 11 , 2010
    DRIVE4COPD Makes Its Mark on American Health
  • May 25, 2010
    Zantac Teams with Travel Channel for “Beat the Heat” Tour
  • May 20, 2010
    Boehringer Ingelheim to present new data regarding its investigational compound BIBW 2992 in head and neck cancer and non-small cell lung cancer
  • May 18, 2010
    Boehringer Ingelheim Announces New Data on Flibanserin in Pre-Menopausal Women with Hypoactive Sexual Desire Disorder
  • May 12, 2010
    When it Comes to Sparking a Woman's Sexual Desire, Most Men - and Even Women - May Not Know Where to Start
  • May 10 , 2010
    New Survey Finds Parents Need Help Encouraging Their Kids in Science
  • April 22, 2010
    New Boehringer Ingelheim Science Quest Mobile Laboratory Brings Hands-On Science Education to Priority Connecticut Elementary Schools
  • April 20, 2010
    Boehringer Ingelheim grows faster than the pharmaceutical market for the tenth time in succession/continued high level of investment in R&D/market launch of five innovative medicines planned
  • April 13, 2010
    FDA maintains essential use status of Combivent (ipratropium bromide and albuterol sulfate) Inhalation Aerosol through 2013
  • March 23, 2010
    Once-daily MIRAPEX ER now approved by FDA for both early and advanced Parkinson’s disease
  • March 11, 2010
    Diabetes Experts Call for Early, Integrated Treatment Approach to Help Prevent Complications and Improve Patient Outcomes
  • February 22, 2010
    FDA approves once-daily MIRAPEX ER for the treatment of early Parkinson's disease
  • February 18, 2010
    Celebrities ‘Tweet’ to Drive COPD Awareness and Action
  • February 18, 2010
    New Research Shows Emotional Impact of Low Sexual Desire and Associated Distress on Women
  • February 3, 2010
    DRIVE4COPD Sheds Light on the Nation's 4th Leading Killer Through Unprecedented Public Health Initiative
  • February 3, 2010
    Boehringer Ingelheim Employee Shares a Personal Account of the Haiti Earthquake
  • January 14, 2010
    Boehringer Ingelheim Cares Foundation Assists in Haiti Disaster Relief